Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Plos One|August 24, 2012
Plexin-B2 and Plexin-D1 in dendritic cells: expression and IL-12/IL-23p40 productionEda K Holl, Kelly E Roney, Irving C Allen, et al.
Gut|October 16, 2010
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitisWilliam J Sandborn, Jean Frederic Colombel, Matthew Frankel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2023
Preclinical Serological Signatures are Associated With Complicated Crohn's Disease Phenotype at DiagnosisRok Seon Choung, Francesca Petralia, Joana Torres, et al.
Gastroenterology|February 24, 2009
Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's diseaseXiaonan Han, Kanji Uchida, Ingrid Jurickova, et al.
Gastroenterology|March 7, 2016
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic ResectionMiguel Regueiro, Brian G Feagan, Bin Zou, et al.
Gastroenterology|March 14, 2020
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before DiagnosisJoana Torres, Francesca Petralia, Takahiro Sato, et al.
The American Journal of Gastroenterology|October 16, 2013
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imagingWilliam A Faubion, Joel G Fletcher, Sharon O'Byrne, et al.
Gastroenterology|July 8, 2018
Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative ColitisShannon E Telesco, Carrie Brodmerkel, Hongyan Zhang, et al.
The American Journal of Gastroenterology|November 4, 2010
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?Geert R D'Haens, Remo Panaccione, Peter D R Higgins, et al.
Gastroenterology|May 27, 2022
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's DiseaseArthur Mortha, Romain Remark, Diane Marie Del Valle, et al.
Pageof 4